peroxynitrous acid has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, S; Ishizuka, M; Kazusaka, A; Muzandu, K; Shaban, Z | 1 |
| Andrekopoulos, C; Huh, J; Kalyanaraman, B; Liepins, A; Sorokin, A; Zielonka, J | 1 |
2 other study(ies) available for peroxynitrous acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Nitric oxide enhances catechol estrogen-induced oxidative stress in LNCaP cells.
Topics: Antioxidants; Cell Line, Tumor; Comet Assay; DNA Damage; Estrogens, Catechol; Humans; Male; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Plasmids; Prostatic Neoplasms; Reactive Oxygen Species | 2005 |
Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity.
Topics: Adenoviridae; Alkaloids; Apoptosis; Benzophenanthridines; Cell Line, Tumor; Cyclooxygenase 2; Epithelial Cells; Gene Transfer Techniques; Humans; Isoquinolines; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peroxynitrous Acid; Prostatic Neoplasms | 2006 |